학술논문
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Document Type
Short Communication
Author
Source
In European Neuropsychopharmacology September 2023 74:15-21
Subject
Language
ISSN
0924-977X